• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用纯化的P-糖蛋白来理解多药耐药性。

Using purified P-glycoprotein to understand multidrug resistance.

作者信息

Shapiro A B, Ling V

机构信息

Division of Molecular and Structural Biology, Ontario Cancer Institute, Toronto, Canada.

出版信息

J Bioenerg Biomembr. 1995 Feb;27(1):7-13. doi: 10.1007/BF02110325.

DOI:10.1007/BF02110325
PMID:7629053
Abstract

Since P-glycoprotein was discovered almost 20 years ago, its causative role in multidrug resistance has been established, but central problems of its biochemistry have not been definitively resolved. Recently, major advances have been made in P-glycoprotein biochemistry with the use of purified and reconstituted P-glycoprotein, as well as membranes from nonmammalian cells containing heterologously expressed P-glycoprotein. In this review we describe recent findings using these systems which are elucidating the molecular mechanism of P-glycoprotein-mediated drug transport.

摘要

自从大约20年前发现P-糖蛋白以来,其在多药耐药性中的致病作用已得到确立,但其生物化学的核心问题尚未得到最终解决。最近,利用纯化和重组的P-糖蛋白以及含有异源表达P-糖蛋白的非哺乳动物细胞膜,P-糖蛋白生物化学取得了重大进展。在这篇综述中,我们描述了使用这些系统的最新发现,这些发现正在阐明P-糖蛋白介导的药物转运的分子机制。

相似文献

1
Using purified P-glycoprotein to understand multidrug resistance.利用纯化的P-糖蛋白来理解多药耐药性。
J Bioenerg Biomembr. 1995 Feb;27(1):7-13. doi: 10.1007/BF02110325.
2
Characterization and functional reconstitution of the multidrug transporter.多药转运蛋白的特性鉴定与功能重建
J Bioenerg Biomembr. 1995 Feb;27(1):15-22. doi: 10.1007/BF02110326.
3
Purification and reconstitution of functional human P-glycoprotein.功能性人P-糖蛋白的纯化与重组
J Bioenerg Biomembr. 1995 Feb;27(1):23-9. doi: 10.1007/BF02110327.
4
P-glycoprotein-mediated multidrug resistance in tumor cells: biochemistry, clinical relevance and modulation.P-糖蛋白介导的肿瘤细胞多药耐药性:生物化学、临床相关性及调控
Mol Aspects Med. 1995;16(1):1-78. doi: 10.1016/0098-2997(94)00040-a.
5
Reconstitution of purified P-glycoprotein into liposomes.将纯化的P-糖蛋白重组到脂质体中。
J Cancer Res Clin Oncol. 1995;121(9-10):582-6. doi: 10.1007/BF01197774.
6
Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells.P-糖蛋白多药转运体(MDR1)与高亲和力肽类化学增敏剂在分离膜、重组系统及完整细胞中的相互作用。
Biochem Pharmacol. 1999 Aug 15;58(4):571-86. doi: 10.1016/s0006-2952(99)00139-2.
7
ATP hydrolysis by multidrug-resistance protein from Chinese hamster ovary cells.中国仓鼠卵巢细胞多药耐药蛋白的ATP水解作用
J Bioenerg Biomembr. 1995 Feb;27(1):31-6. doi: 10.1007/BF02110328.
8
The P-glycoprotein multidrug transporter: interactions with membrane lipids, and their modulation of activity.P-糖蛋白多药转运体:与膜脂的相互作用及其对活性的调节
Biochem Soc Trans. 1997 Aug;25(3):1088-96. doi: 10.1042/bst0251088.
9
Drug-stimulatable ATPase activity in crude membranes of human MDR1-transfected mammalian cells.人MDR1转染哺乳动物细胞粗膜中药物刺激的ATP酶活性。
Methods Enzymol. 1998;292:504-14. doi: 10.1016/s0076-6879(98)92039-0.
10
Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate.P-糖蛋白介导的若丹明染料从多药耐药细胞中排出的效率取决于其被动跨膜移动速率。
Eur J Biochem. 1997 Aug 15;248(1):104-12. doi: 10.1111/j.1432-1033.1997.00104.x.

引用本文的文献

1
Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine.依度沙班与酮康唑、红霉素及环孢素的药物相互作用。
Br J Clin Pharmacol. 2016 Dec;82(6):1591-1600. doi: 10.1111/bcp.13092. Epub 2016 Sep 23.
2
A Network Biology Approach to Decipher Stress Response in Bacteria Using Escherichia coli As a Model.一种以大肠杆菌为模型解析细菌应激反应的网络生物学方法。
OMICS. 2016 May;20(5):310-24. doi: 10.1089/omi.2016.0028.
3
Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin.

本文引用的文献

1
Intracellular pH and the control of multidrug resistance.细胞内pH值与多药耐药性的控制
Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1128-32. doi: 10.1073/pnas.91.3.1128.
2
Lower electrical membrane potential and altered pHi homeostasis in multidrug-resistant (MDR) cells: further characterization of a series of MDR cell lines expressing different levels of P-glycoprotein.多药耐药(MDR)细胞中较低的膜电位和改变的细胞内pH稳态:一系列表达不同水平P-糖蛋白的MDR细胞系的进一步特征分析
Biochemistry. 1993 Oct 19;32(41):11042-56. doi: 10.1021/bi00092a014.
3
Changes in intra- or extracellular pH do not mediate P-glycoprotein-dependent multidrug resistance.
槲皮素作为一种潜在的调节剂,可调节对柔红霉素耐药的人胰腺癌细胞系中 P-糖蛋白的表达和功能。
Molecules. 2010 Feb 9;15(2):857-70. doi: 10.3390/molecules15020857.
4
Preface: the concept and consequences of multidrug resistance.前言:多重耐药性的概念及后果
Pflugers Arch. 2007 Feb;453(5):545-53. doi: 10.1007/s00424-006-0115-0. Epub 2006 Jul 22.
5
Cancer: a single disease with a multitude of manifestions?癌症:一种具有多种表现形式的单一疾病?
J Carcinog. 2003 Nov 18;2(1):9. doi: 10.1186/1477-3163-2-9.
6
Proton-dependent multidrug efflux systems.质子依赖型多药外排系统
Microbiol Rev. 1996 Dec;60(4):575-608. doi: 10.1128/mr.60.4.575-608.1996.
7
Altered drug translocation mediated by the MDR protein: direct, indirect, or both?由多药耐药蛋白介导的药物转运改变:直接、间接,还是两者皆有?
J Bioenerg Biomembr. 1996 Dec;28(6):541-55. doi: 10.1007/BF02110444.
8
Cellular drug efflux and reversal therapy of cancer.细胞药物外排与癌症的逆转治疗
J Bioenerg Biomembr. 1996 Jun;28(3):279-84. doi: 10.1007/BF02110701.
细胞内或细胞外pH值的变化并不介导P-糖蛋白依赖性多药耐药性。
Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9735-8. doi: 10.1073/pnas.90.20.9735.
4
Fluorescent cellular indicators are extruded by the multidrug resistance protein.荧光细胞指示剂被多药耐药蛋白排出。
J Biol Chem. 1993 Oct 15;268(29):21493-6.
5
Functional consequences of phenylalanine mutations in the predicted transmembrane domain of P-glycoprotein.P-糖蛋白预测跨膜结构域中苯丙氨酸突变的功能后果。
J Biol Chem. 1993 Sep 25;268(27):19965-72.
6
Biochemistry of multidrug resistance mediated by the multidrug transporter.多药转运蛋白介导的多药耐药的生物化学
Annu Rev Biochem. 1993;62:385-427. doi: 10.1146/annurev.bi.62.070193.002125.
7
Membrane topology of the N-terminal half of the hamster P-glycoprotein molecule.仓鼠P-糖蛋白分子N端一半的膜拓扑结构
J Biol Chem. 1993 Jul 15;268(20):15101-10.
8
The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistance.秋水仙碱乙酰胺基中的氮调节P-糖蛋白介导的多药耐药性。
Biochemistry. 1993 Jun 29;32(25):6470-6. doi: 10.1021/bi00076a022.
9
Structure and function of P-glycoprotein in normal liver and small intestine.
Adv Pharmacol. 1993;24:77-97. doi: 10.1016/s1054-3589(08)60934-5.
10
Evidence for an alternate model of human P-glycoprotein structure and biogenesis.人类P-糖蛋白结构与生物发生替代模型的证据。
J Biol Chem. 1993 Apr 5;268(10):6903-8.